Clinical Trial Update: Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection

View source ↗

Summary

A completed clinical trial evaluating a deep learning model to predict recurrence risk after sub-lobar resection in Stage IA invasive lung adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Focus on Developing a Deep Learning Model to Predict the Recurrence Risk of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection | Status: COMPLETED